Y-Intercept (HK)
PBYI icon

Y-Intercept (HK)’s Puma Biotechnology PBYI Stock Holding History

Y-Intercept (HK)’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-26,222
Closed -$213K – 1973
2026
Q2 		$213K Buy
+26,222
New +$192K ﹤0.01% 1559
2024
Q2 		– Sell
-19,383
Closed -$103K – 1790
2024
Q1 		$103K Buy
19,383
+1,437
+8% +$7.74K 0.01% 1276
2023
Q4 		$77.7K Buy
+17,946
New +$59.5K 0.01% 1132

Other funds holding PBYI

Haven Private
Haven Private Orlando, Florida $253M AUM 14.52% 1-Year Est. Return
OpenArc Corporate Advisory
OpenArc Corporate Advisory Atlanta, Georgia $8.86B AUM 19.31% 1-Year Est. Return
SummerHaven Investment Management
SummerHaven Investment Management Stamford, Connecticut $179M AUM 57.61% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
Evergreen Capital Management
Evergreen Capital Management Bellevue, Washington $5.65B AUM 21.62% 1-Year Est. Return
Vise Technologies
Vise Technologies New York $12B AUM 18.78% 1-Year Est. Return
Kathmere Capital Management
Kathmere Capital Management Wayne, Pennsylvania $2.07B AUM 20.3% 1-Year Est. Return
Baron Wealth Management
Baron Wealth Management Troy, Michigan $389M AUM 21.95% 1-Year Est. Return
C2C Wealth Management
C2C Wealth Management Scottsdale, Arizona $128M AUM 19.37% 1-Year Est. Return
Bailard
Bailard Foster City, California $4.94B AUM 25.15% 1-Year Est. Return

Y-Intercept (HK)'s PBYI Position: Q3 2026 in Review

Y-Intercept (HK) sold out of Puma Biotechnology (PBYI) in Q3 2026, closing a stake of 26,222 shares — an estimated $213K sold.

Y-Intercept (HK) first reported a position in PBYI in Q4 2023 and held it in 3 quarters. The position peaked at $213K in Q2 2026. 36 funds tracked by Wall St. Rank hold PBYI as of Q3 2026.

  • Y-Intercept (HK) reported no remaining Puma Biotechnology position as of Q3 2026 after selling out during the quarter.
  • Y-Intercept (HK) sold 26,222 Puma Biotechnology shares in Q3 2026, an estimated $213K.
  • Y-Intercept (HK) first reported a position in Puma Biotechnology in Q4 2023 and held it in 3 quarters.
  • Y-Intercept (HK)'s Puma Biotechnology position peaked at $213K in Q2 2026.
  • 36 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.